{
    "clinical_study": {
        "@rank": "21905", 
        "brief_summary": {
            "textblock": "Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS\n      complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP\n      has increased cancer susceptibility.  We plan to perform careful clinical examination of\n      selected patients with XP, XP/CS, CS, or TTD and follow their clinical course.  We will\n      obtain tissue (skin, blood, hair, buccal swabs) for laboratory examination of DNA repair and\n      for genetic analysis.  We hope to be able to correlate these laboratory abnormalities with\n      the clinical features to better understand the mechanism of cancer prevention by DNA repair.\n       Patients will be offered counseling and education for cancer control."
        }, 
        "brief_title": "Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy", 
        "condition": [
            "Cockayne Syndrome", 
            "Skin Cancer", 
            "Xeroderma Pigmentosum", 
            "Trichothiodystrophy", 
            "Genodermatosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Skin Neoplasms", 
                "Cockayne Syndrome", 
                "Skin Diseases, Genetic", 
                "Ichthyosis", 
                "Xeroderma Pigmentosum", 
                "Trichothiodystrophy Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS\n      complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP\n      has increased cancer susceptibility.  A number of these patients have been identified in\n      Israel.   We plan to perform careful clinical examination of selected patients with XP,\n      XP/CS, CS, or TTD and follow their clinical course.  We will obtain tissue (skin, blood,\n      hair, buccal swabs) for laboratory examination of DNA repair and for genetic analysis.  We\n      hope to be able to correlate these laboratory abnormalities with the clinical features to\n      better understand the mechanism of cancer prevention by DNA repair.  Patients will be\n      offered counseling and education for cancer control."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  ELIGIBILITY CRITERIA:\n\n        Patients with XP, XP/CS, CS, or TTD of any age, gender, race or HIV status are eligible\n        for this study. Patients will be sought by contacting professional organizations (such as\n        the American Academy of Dermatology-XP Task Force), lay support groups (such as the XP\n        Society and the Share and Care CS Support Network) or by direct referral.\n\n        INCLUSION CRITERIA:\n\n        On referral, patients will be considered for inclusion in the study:\n\n        If they have clinical documentation of typical features of XP, XP/CS, CS or TDD or;\n\n        If they have laboratory documentation of defective DNA repair, or;\n\n        If they have some suggestive clinical features and are willing to participate in the\n        study.\n\n        EXCLUSION CRITERIA:\n\n        Inability or unwillingness to provide tissue (skin, blood, buccal cells or hair) for\n        laboratory studies."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT00004044", 
            "nct_id": "NCT00001813", 
            "org_study_id": "990099", 
            "secondary_id": "99-C-0099"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Xeroderma Pigmentosum", 
            "Trichothiodystrophy", 
            "Cockayne Syndrome", 
            "Skin Cancer", 
            "DNA Repair"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1999-C-0099.html"
        }, 
        "location": {
            "contact": {
                "last_name": "For more information at the NIH Clinical Center contact National Cancer Institute Referral Office", 
                "phone": "(888) NCI-1937"
            }, 
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy", 
        "overall_contact": {
            "email": "tamurad@mail.nih.gov", 
            "last_name": "Deborah E Tamura, R.N.", 
            "phone": "(301) 594-5030"
        }, 
        "overall_contact_backup": {
            "email": "kraemerk@mail.nih.gov", 
            "last_name": "Kenneth H Kraemer, M.D.", 
            "phone": "(301) 496-9033"
        }, 
        "overall_official": {
            "affiliation": "National Cancer Institute (NCI)", 
            "last_name": "Kenneth H Kraemer, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "measure": "Identify four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD)", 
            "safety_issue": "No", 
            "time_frame": "Up to 3 days"
        }, 
        "reference": [
            {
                "PMID": "9734359", 
                "citation": "Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, Bootsma D, Hoeijmakers JH. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell. 1998 Aug;2(2):223-32."
            }, 
            {
                "PMID": "2779780", 
                "citation": "Boltshauser E, Yalcinkaya C, Wichmann W, Reutter F, Prader A, Valavanis A. MRI in Cockayne syndrome type I. Neuroradiology. 1989;31(3):276-7."
            }, 
            {
                "PMID": "23928520", 
                "citation": "Viana LM, Seyyedi M, Brewer CC, Zalewski C, DiGiovanna JJ, Tamura D, Totonchy M, Kraemer KH, Nadol JB Jr. Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration. Otol Neurotol. 2013 Sep;34(7):1230-6. doi: 10.1097/MAO.0b013e31829795e9."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001813"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 1999", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}